Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 2
2012 3
2013 4
2014 5
2015 2
2016 4
2017 6
2018 5
2019 6
2020 6
2021 7
2022 5
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Medulloblastoma: experimental models and reality.
Neumann JE, Swartling FJ, Schüller U. Neumann JE, et al. Among authors: swartling fj. Acta Neuropathol. 2017 Nov;134(5):679-689. doi: 10.1007/s00401-017-1753-3. Epub 2017 Jul 19. Acta Neuropathol. 2017. PMID: 28725965 Review.
Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma.
Borgenvik A, Holmberg KO, Bolin S, Zhao M, Savov V, Rosén G, Hutter S, Garancher A, Rahmanto AS, Bergström T, Olsen TK, Mainwaring OJ, Sattanino D, Verbaan AD, Rusert JM, Sundström A, Bravo MB, Dang Y, Wenz AS, Richardson S, Fotaki G, Hill RM, Dubuc AM, Kalushkova A, Remke M, Čančer M, Jernberg-Wiklund H, Giraud G, Chen X, Taylor MD, Sangfelt O, Clifford SC, Schüller U, Wechsler-Reya RJ, Weishaupt H, Swartling FJ. Borgenvik A, et al. Among authors: swartling fj. Cancer Res. 2022 Dec 16;82(24):4586-4603. doi: 10.1158/0008-5472.CAN-22-2108. Cancer Res. 2022. PMID: 36219398 Free PMC article.
Oncoprotein stabilization in brain tumors.
Hede SM, Savov V, Weishaupt H, Sangfelt O, Swartling FJ. Hede SM, et al. Among authors: swartling fj. Oncogene. 2014 Sep 25;33(39):4709-21. doi: 10.1038/onc.2013.445. Epub 2013 Oct 28. Oncogene. 2014. PMID: 24166497 Review.
Targeting MYCN in Molecularly Defined Malignant Brain Tumors.
Borgenvik A, Čančer M, Hutter S, Swartling FJ. Borgenvik A, et al. Among authors: swartling fj. Front Oncol. 2021 Jan 28;10:626751. doi: 10.3389/fonc.2020.626751. eCollection 2020. Front Oncol. 2021. PMID: 33585252 Free PMC article. Review.
What underlies the diversity of brain tumors?
Swartling FJ, Hede SM, Weiss WA. Swartling FJ, et al. Cancer Metastasis Rev. 2013 Jun;32(1-2):5-24. doi: 10.1007/s10555-012-9407-3. Cancer Metastasis Rev. 2013. PMID: 23085857 Free PMC article. Review.
Deregulated proliferation and differentiation in brain tumors.
Swartling FJ, Čančer M, Frantz A, Weishaupt H, Persson AI. Swartling FJ, et al. Cell Tissue Res. 2015 Jan;359(1):225-54. doi: 10.1007/s00441-014-2046-y. Epub 2014 Nov 23. Cell Tissue Res. 2015. PMID: 25416506 Free PMC article. Review.
ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors.
Mainwaring OJ, Weishaupt H, Zhao M, Rosén G, Borgenvik A, Breinschmid L, Verbaan AD, Richardson S, Thompson D, Clifford SC, Hill RM, Annusver K, Sundström A, Holmberg KO, Kasper M, Hutter S, Swartling FJ. Mainwaring OJ, et al. Among authors: swartling fj. Nat Commun. 2023 Mar 3;14(1):1221. doi: 10.1038/s41467-023-36847-9. Nat Commun. 2023. PMID: 36869047 Free PMC article.
Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma.
Simonds EF, Lu ED, Badillo O, Karimi S, Liu EV, Tamaki W, Rancan C, Downey KM, Stultz J, Sinha M, McHenry LK, Nasholm NM, Chuntova P, Sundström A, Genoud V, Shahani SA, Wang LD, Brown CE, Walker PR, Swartling FJ, Fong L, Okada H, Weiss WA, Hellström M. Simonds EF, et al. Among authors: swartling fj. J Immunother Cancer. 2021 Jun;9(6):e002181. doi: 10.1136/jitc-2020-002181. J Immunother Cancer. 2021. PMID: 34083417 Free PMC article.
50 results